Attorney General secures $35 Novo Nordisk insulin for Minnesotans
The settlement resolves the Attorney General’s 2018 lawsuit alleging that Novo Nordisk deceptively priced its insulin.
Albert Lea Tribune4d
Insulin capped at $35 per month for Minnesotans, after settlement with manufacturers
Minnesotans prescribed insulin won’t pay more than $35 per month for it, after the conclusion of a lawsuit against three ...
pharmaphorum4d
Novo's Tresiba primed for key 'hypo' label update in EU
Novo Nordisk's long-acting insulin Tresiba is set to gain new ... where biosimilars are driving down prices of Sanofi’s drug. Tresiba was approved by the FDA in 2015 on the basis of top-line ...
pharmaphorum6d
Novo cleared to add key data to Tresiba label
The FDA has ruled that Novo can include data from the Devote study on Tresiba’s (insulin degludec ... was the recent US launch of its new GLP-1 drug Ozempic (semaglutide), which is expected ...
Fact Check: Insulin cap for Medicare unaffected by Trump order on prescription drug costs
A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...
KAAL TV4d
Novo Nordisk insulin now $35 per month for Minnesotans thanks to Attorney General Keith Ellison
Attorney General Keith Ellison announced a settlement with Novo Nordisk that let's Minnesotans buy its insulin products for ...
Kaleido Scope4d
Garvey receives Gerald Reavan Distinguished Leader in Insulin Resistance Award
Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.